Matthew Sung

1.4k total citations
18 papers, 823 citations indexed

About

Matthew Sung is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Matthew Sung has authored 18 papers receiving a total of 823 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 7 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Matthew Sung's work include Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Ubiquitin and proteasome pathways (3 papers). Matthew Sung is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (7 papers), HER2/EGFR in Cancer Research (6 papers) and Ubiquitin and proteasome pathways (3 papers). Matthew Sung collaborates with scholars based in United States, United Kingdom and Australia. Matthew Sung's co-authors include Hans‐Peter Gerber, Frank Loganzo, Paraskevi Giannakakou, Alexandre Matov, David M. Nanus, Stephen R. Plymate, Maria Thadani‐Mulero, Robert L. Vessella, Shihua Sun and Eva Corey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cancer Research.

In The Last Decade

Matthew Sung

17 papers receiving 814 citations

Peers

Countries citing papers authored by Matthew Sung

Since Specialization

Citations

This map shows the geographic impact of Matthew Sung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Sung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Sung more than expected).

Fields of papers citing papers by Matthew Sung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Sung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Sung. The network helps show where Matthew Sung may publish in the future.

Co-authorship network of co-authors of Matthew Sung

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Sung. A scholar is included among the top collaborators of Matthew Sung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Sung. Matthew Sung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Abstract 7149: The role of TROP2 in the MoA of Dato-DXd and how it underpins the biologic rationale of the novel AI-guided biomarker TROP2 normalized membrane ratio 2025 ·Cancer Research ·Matthew Sung, Matthew E. Wilson, Dominik Vonficht, Armin Meier, Chetan K. Rane, (unknown), Gopi Patel, (unknown), Yann Wallez, Xiaochuan Liu, R. J. Hill, James A. Harper, (unknown), Hadassah Sade, Danielle Carroll	0
2	Quantitative evaluation of trastuzumab deruxtecan pharmacokinetics and pharmacodynamics in mouse models of varying degrees of HER2 expression 2024 ·CPT Pharmacometrics & Systems Pharmacology ·(unknown), Theresa A. Proia, (unknown), (unknown), Matthew Sung, Srinivas Mamidi, (unknown), Matthew Griffin, (unknown), Jelena Urosevic, Anton I. Rosenbaum, Jiaqi Yuan, Krishna Aluri, Diane Ramsden, Niresh Hariparsad, Rhys D.O. Jones, Jerome T. Mettetal	7
3	Abstract 5618: Evaluating the combination of datopotamab deruxtecan (Dato-DXd) with AZD5305, a highly potent, PARP1-selective inhibitor, -in preclinical models 2024 ·Cancer Research ·Gopi Patel, (unknown), Chetan K. Rane, Alan Rosen, Matt J. Griffin, Matthew Sung	3
4	Abstract 1911: Dato-DXd mediates anti-tumor activity in preclinical TROP2-expressing intracranial tumor model 2024 ·Cancer Research ·(unknown), (unknown), (unknown), Jacob A. Gordon, Corinne Reimer, Matthew Sung, Chetan K. Rane	1
5	Pan-Cancer Proteomics Analysis to Identify Tumor-Enriched and Highly Expressed Cell Surface Antigens as Potential Targets for Cancer Therapeutics 2023 ·Molecular & Cellular Proteomics ·(unknown), (unknown), (unknown), (unknown), Matthew E. Wilson, Matthew Sung, (unknown), Elaine M. Hurt, Gina D’Angelo, Ben S. Sidders, Zhongwu Lai, Wenyan Zhong	4
6	Abstract LB227: Leveraging novel Dato-DXd resistance models to inform biomarker discovery and rational combinations to combat drug resistance 2023 ·Cancer Research ·(unknown), Chetan K. Rane, Gopi Patel, Deepa Bhavsar, Shenghua Wen, David Clark, Yeoun Jin Kim, Alan Lau, Yann Wallez, (unknown), Wenyan Zhong, Matthew Sung	3
7	Use of translational modeling and simulation for quantitative comparison of PF-06804103, a new generation HER2 ADC, with Trastuzumab-DM1 2020 ·Journal of Pharmacokinetics and Pharmacodynamics ·Alison Betts, Tracey Clark, Paul Jasper, John Tolsma, Piet H. van der Graaf, Edmund I. Graziani, Edward Rosfjord, Matthew Sung, Dangshe Ma, Frank Barletta	19
8	Abstract 818: NG-HER2 ADC (PF-06804103) is superior to trastuzumab emtansine in a mouse 'avatar' head-to-head clinical trial 2018 ·Cancer Research ·Matthew Sung, (unknown), Erik Upeslacis, Jonathon Golas, (unknown), Kiran Khandke, Manoj B. Charati, Frank W. Kotch, Frank Loganzo, (unknown), Judy Lucas, Hans‐Peter Gerber, Puja Sapra, Edward Rosfjord	6
9	Caveolae-Mediated Endocytosis as a Novel Mechanism of Resistance to Trastuzumab Emtansine (T-DM1) 2017 ·Molecular Cancer Therapeutics ·Matthew Sung, Xingzhi Tan, Bingwen Lu, Jonathan Golas, Christine Hosselet, Fang Wang, Laurie Tylaska, Lindsay King, Dahui Zhou, Russell G. Dushin, Jeremy S. Myers, Edward Rosfjord, Judy Lucas, Hans‐Peter Gerber, Frank Loganzo	155
10	Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia 2017 ·Neoplasia ·Cathy C. Zhang, Zhengming Yan, Bernadette Pascual, Amy Jackson-Fisher, Donghui Huang, (unknown), Mark Elliott, (unknown), Nanni Huser, Joseph Lee, Matthew Sung, Puja Sapra	16
11	Abstract 3095: The development of CPI as a novel, next-generation DNA-targeting payload for ADCs 2017 ·Cancer Research ·Jennifer Kahler, Maureen Dougher, (unknown), (unknown), Andreas Maderna, Russell G. Dushin, Stéphane Thibault, Mauricio Leal, Madan Katragadda, Christopher J. O’Donnell, Matthew Sung, Puja Sapra	1
12	Abstract 2113: Caveolae-mediated endocytosis as a novel mechanism of resistance to T-DM1 ADC 2016 ·Cancer Research ·Matthew Sung, Xingzhi Tan, Christine Hosselet, (unknown), Erik Upeslacis, Jonathon Golas, Fang Wang, Bingwen Lu, Laurie Tylaska, Lindsay King, Jeremy S. Myers, Edward Rosfjord, Judy Lucas, Hans‐Peter Gerber, Frank Loganzo	3
13	Mechanisms of Resistance to Antibody–Drug Conjugates 2016 ·Molecular Cancer Therapeutics ·Frank Loganzo, Matthew Sung, Hans‐Peter Gerber	150
14	Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer 2014 ·Cancer Research ·Maria Thadani‐Mulero, Luigi Portella, Shihua Sun, Matthew Sung, Alexandre Matov, Robert L. Vessella, Eva Corey, David M. Nanus, Stephen R. Plymate, Paraskevi Giannakakou	191
15	ERG induces taxane resistance in castration-resistant prostate cancer 2014 ·Nature Communications ·Giuseppe Galletti, Alexandre Matov, Himisha Beltran, Jacqueline Fontugne, Juan Miguel Mosquera, Cynthia Cheung, Theresa Y. MacDonald, Matthew Sung, Sandra O’Toole, James G. Kench, Sung Suk Chae, Dragi Kimovski, Scott T. Tagawa, David M. Nanus, Mark A. Rubin, Lisa G. Horvath, Paraskevi Giannakakou, David S. Rickman	97
16	NAD ⁺ and SIRT3 control microtubule dynamics and reduce susceptibility to antimicrotubule agents 2014 ·Proceedings of the National Academy of Sciences ·(unknown), Ananda K. Ghosh, Matthew Sung, Alexandre Matov, Kevin D. Brown, Paraskevi Giannakakou, Samie R. Jaffrey	31
17	BRCA1 regulates microtubule dynamics and taxane-induced apoptotic cell signaling 2013 ·Oncogene ·Matthew Sung, (unknown)	46
18	Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device 2013 ·Lab on a Chip ·Giuseppe Galletti, Matthew Sung, Linda T. Vahdat, Manish A. Shah, Steven M. Santana, Giuseppe Altavilla, Brian J. Kirby, Paraskevi Giannakakou	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact